HematoLogics Inc., 3161 Elliott Ave, Seattle, WA 98121, USA.
Leuk Res. 2011 Dec;35(12):1597-604. doi: 10.1016/j.leukres.2011.06.012. Epub 2011 Jul 14.
Flow cytometric cell sorting combined with molecular gene rearrangement analysis was used to detect and to further characterize simultaneously occurring phenotypically distinct B cell monoclonal lymphoid and monoclonal plasma cell populations from 38 individual specimens. By sorting and subsequent gene rearrangement analysis, separate or identical monoclonality genotypes could be revealed and confirmed. In only 13 of 38 specimens, the B lymphoid cells and plasma cell populations showed an identical genotypic profile, while 25 had non-identical profiles (including 4 process control specimens). The majority of the genotypically identical group had a phenotype consistent with Waldenström's/lymphoplasmacytic lymphoma (WM/LPL), while WM/LPL phenotype was present in 16/25 of the non-identical cases. Proof of an identical monoclonal genotype for plasmacytic and B-lymphoid cell populations must be used to define WM/LPL as a distinct entity in the clinical setting of monoclonal lymphoid and plasma cells expressing the same light chains. Conversely, the confirmation of genotypically distinct populations can significantly improve confidence in diagnostic and prognostic decisions in specimens with B lymphoid lymphomas and a concurrent, possibly smoldering myeloma or multiple myeloma. These techniques are requisite in future clinical studies for diagnosis and prognosis in these diseases.
流式细胞术细胞分选结合分子基因重排分析用于检测和进一步表征 38 个单独标本中同时发生的表型不同的 B 细胞单克隆淋巴样和单克隆浆细胞群体。通过分选和随后的基因重排分析,可以揭示和确认单独或相同的单克隆性基因型。在 38 个标本中,只有 13 个 B 淋巴细胞和浆细胞群体显示出相同的基因型谱,而 25 个具有不同的基因型谱(包括 4 个过程对照标本)。大多数基因型相同的群体具有与 Waldenström 氏巨球蛋白血症/淋巴浆细胞淋巴瘤(WM/LPL)一致的表型,而在 25 个非相同病例中,有 16 个存在 WM/LPL 表型。为了将 WM/LPL 定义为具有相同轻链的单克隆淋巴样和浆细胞群中具有独特实体的疾病,必须证明浆细胞和 B 淋巴细胞群体具有相同的单克隆基因型。相反,在具有 B 淋巴细胞淋巴瘤和同时存在的可能潜伏性骨髓瘤或多发性骨髓瘤的标本中,确认基因型不同的群体可以显著提高对诊断和预后决策的信心。这些技术是未来这些疾病诊断和预后的临床研究所必需的。